Phase 1, First-in-Human Study of RAD140 in Postmenopausal Women With Breast Cancer

Clinical trial NCT03088527 · COMPLETED

Trial details

NCT number: NCT03088527
Sponsor: Stemline Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hormone Receptor Positive Malignant Neoplasm of Breast

Start date: 2017-10-23
Primary completion: 2020-08-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.